No Data
dong-e-e-jiao (000423): The performance is growing rapidly and the quality of operation is continuously improving.
On the evening of October 30, the company released the performance report for the first three quarters of 2024, achieving revenue of 4.329 billion yuan, a year-on-year growth of 26.28%, and achieving net income attributable to the parent company of 1.152 billion yuan, a year-on-year growth of 4.
Zheshang: Innovative drugs, blood products and other fields may benefit from the slow recovery on the demand side.
Zheshang released research reports stating that the transition of pharmaceutical new and old kinetic energy will continue in the next stage, with innovative drugs, supply cleaning or better framework in areas such as innovative drug supporting industry chain, large infusion, anesthetic drugs, blood products, pharmaceutical circulation, traditional chinese medicine OTC, benefiting from the slow recovery on the demand side, potentially with better growth prospects.
A settlement code traced back over 40 times! Dong-e-e-jiao pharmaceutical "traceability gate" involves 46 medical institutions, the medical insurance bureau suspects empty swiping of medical insurance, and drug substitution behavior.
The National Healthcare Security Administration will focus on verifying the substitution of pharmaceuticals, the possibility of fraudulent medical insurance claims, and the return of medications, conducting in-depth investigations into why the same box of medication can be sold dozens of times to different insured individuals by the same hospital clinics and pharmacies, or repeatedly sold by different institutions.
Express News | Regarding a box of compound Asini Gelatinum Syrup settlement for 60 times, the latest response from the National Medical Insurance Administration.
Dong-E-E-Jiao Co.,Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Express News | dong-e-e-jiao Statement: Actively responding to the relevant announcement of the National Medical Insurance Administration.
No Data
No Data